Impact of remote monitoring on the management of arrhythmias in patients with implantable cardioverter-defibrillator

Journal of Cardiovascular Medicine

Volumn 16, Issue 11, 2015, Pages 775-781

  Marcantoni, Lina ^a   Toselli, Tiziano ^a   Urso, Giulia ^a   Pratola, Claudio ^a   Ceconi, Claudio ^a   Bertini, Matteo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Arrhythmias; Hospitalizations; ICD; Remote monitoring; Shocks

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT ATRIUM; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; REMOTE SENSING; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; EVALUATION STUDY; LONG TERM CARE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; REMOTE SENSING TECHNOLOGY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84943450369     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000148     Document Type: Article

References (25)

1. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines f or management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Soc iety. Eur Heart J 2006; 27:2099-2140.
2. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): descriptio n of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC ) , the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10:707-725.
3. Burri H,Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators Europace 2009 11 701-709.
4. Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system us ed in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Am Heart J 2007; 154:1029-1034.
5. Varma N, Michalski J, Epstein AE, Sch weikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol 2010; 3:428-436.
6. Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 2010; 122:2359-23 67.
7. Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies o f heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012; 125:2985-2992.
8. Ricci RP, Vicentini A, D'Onofrio A, et al. Impact of in-clinic follow-up visits in pat ients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population. J Interv Card Electrophysiol 2013; 38:101-106.
9. Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin Electrophysiol 2005; 28 (Suppl 1):S133-S136.
10. Varma N. Remote monitoring for advisories: automatic early detection of silent lead failure. Pacing Clin Electrophysiol 2009; 32:525-527.
11. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoring technolog y improves detection and clinical management of atrial fibrillation. Europace 2009; 11:54-61.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and, stratification. Am J Kidney Dis 2002; 39:S1-S266.
13. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echoca rdiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
14. Wallbruck K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E. The value of permanent follow-up of implantable pacemakers: first results of an European trial. Biomed Tech (Berl) 2002; 47 (Suppl 1 Pt 2):950-953.
15. Morichelli L, Ricci RP. Remote monitoring of implantable devices: the European experience. Heart Rhythm 2009; 6:1077-1080.
16. Ricci RP, Morichelli L, Quarta L, et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 2010; 12:674-679.
17. Costa-Lobos A, Rile y JP, Cowie MR. Current and future technologies for remote monitoring in cardiology and evidence from trial data. Future Cardiol 2012; 8:425-437.
18. Dubner S, Auricchio A, Steinberg JS, et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17:36-56.
19. Marinskis G, van Erven L, Bongiorni MG, Lip GY, Pison L, Blomstrom-Lundqvist C. Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. E uropace 2012; 14:423-425.
20. Mascioli G, Curnis A, Landolina M, Klersy C, Gelmini GP, Ruffa F. Actions elicited during scheduled and unscheduled in-hospital follow-up of cardiac devices: resu lts of the ATHENS multicentre registry. Europace 2011; 13:1766-1773.
21. Ricci RP, Calcagnini G, Castro A, et al. Consensus document on remote monitoring of cardiac implantable electronic devices : technology, indications, organizational models, acceptability, responsibility, and economic issues. G Ital Cardiol (Rome) 2011; 12:450-467.
22. Ricci RP, Morichelli L, Gargaro A, Laudadio MT, Sa ntini M. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations. J Cardiovasc Electrophysiol 2009; 20:1244-1251.
23. Guedon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34:605-614.
24. Rossi A, Temporelli PL, Quintana M, et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-Analysis of longitudinal data (M eRGE Heart Failure). Eur J Heart Fail 2009; 11:929-936.
25. Hirsh DS, Chinitz LA, Bernstein NE, Holmes DS, Rao S, Aizer A. Clinical comparison of ICD detection algorithms that include rapi d-VT zones. Pacing Clin Electrophysiol 2012; 35:1222-1231.